🗨 🚀 Listen to the interesting conversation with our CEO Richard Francis. He talks about the transformation Teva is going through and the huge steps we are making. Encouraging to hear. #weareallinforbetterhealth #tevapharm #pharmastrategy #innovativemedicines #futuregrowth
At the fireside chat at Bank of America's 2024 Global Healthcare Conference this morning, we have been discussing Teva's #PivottoGrowth with Jason Gerberry and the positive change we have been driving through our pivot to a diversified global pharmaceutical company, not solely a generics company. The recent upgrade by Fitch Ratings – moving us up a notch to BB, is a clear validation of our strategy and how we successfully evolve our business to lead in innovative medicines and biosimilars while continuing a more focused approach to generic medicines. We are constantly delivering against the clear path to growth, and as I've said at the conference - for me the most pleasing part of this is the recognition to the work our teams are so dedicatedly doing. Catch the full discussion here: https://lnkd.in/eWzEQ9c4